falsefalse

My Treatment Approach: Recent Advances in the Treatment of Multiple Myeloma in Early Relapse - Episode 9

Selecting Patients for Treatment With DARA-Kd

,

Peter Forsberg, MD, offers insight into which patients with multiple myeloma are most suitable for treatment with the DARA-Kd regimen.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Patient Profile 1: A 63-Year-Old Female with Relapsed Multiple Myeloma
    EP. 2: Treatment Options for Patients with Multiple Myeloma in Early Relapse
    EP. 3: IKEMA Trial of Isatuximab plus Carfilzomib and Dexamethasone in R/R MM
    EP. 4: Clinical Implications of the IKEMA Trial in R/R MM
    EP. 5: Selecting the Appropriate Patients With MM for Treatment With Isa-Kd
    EP. 6: Treatment of Patients With MM and High-Risk Cytogenetics
    EP. 7: Patient Profile 2: A 76-Year-Old Female with R/R MM
    EP. 8: CANDOR Trial of Daratumumab Plus Carfilzomib and Dexamethasone in R/R MM
    Now Viewing
    EP. 9: Selecting Patients for Treatment With DARA-Kd
    EP. 10: Sequencing Therapies in Patients With R/R MM
    EP. 11: Advice for Community Oncologists Treating Patients With R/R MM

    Related Content:

    My Treatment Approach: Recent Advances in the Treatment of Multiple Myeloma in Early RelapseMultiple MyelomaInsights
    Maximizing Patient Outcomes for IO Sequencing in Advanced EC
    Unmet Needs and Gaps in Treatment Options for Advanced EC Post-IO Therapy
    Five Under 5: Top Oncology Videos for the Week of 4/27
    x